The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma

Cancer Surveys

Volumn 30, Issue , 1997, Pages 59-75

  Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE;

CHROMOSOMAL LOCALIZATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CYTOGENETICS; GENE EXPRESSION; GENE MAPPING; GENE REARRANGEMENT; GLIOBLASTOMA; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW;

GENE REARRANGEMENT; HODGKIN DISEASE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, LARGE-CELL, KI-1; NUCLEAR PROTEINS; PROTEIN-TYROSINE KINASES; TRANSLOCATION, GENETIC;

EID: 0030767794     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Adachi Y, Copeland TD, Hatanaka M and Oroszlan S (1993) Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23. Journal of Biological Chemistry 268 13930-13934
2. al Saati T, Delecluze HJ, Chittal S et al. (1992) A novel human lymphoma cell line (Deglis) with dual B/T phenotype and gene rearrangements and containing Epstein-Barr virus genomes. Blood 80 209-216
3. Amakawa R, Hakem A, Kundig TM et al. (1996) Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84 551-562
4. Ansari MQ, Dawson DB, Nador R et al. (1996) Primary body cavity-based AIDS-related lymphomas. American Journal of Clinical Pathology 105 221-229
5. Beylot-Barry M, Lamant L, Vergier B et al. (1996) Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. American Journal of Pathology 149 483-492
6. Bischof D, Pulford K, Mason DY and Morris SW (1997) Role of nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Molecular and Cellular Biology 17 2312-2325
7. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H and Croce CM (1994) Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Research 54 2873-2877
8. Burnett RC, David JC, Harden AM, LeBeau MM, Rowley JD and Diaz MO (1991) The LCK gene is involved in the t(l;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2. Genes, Chromosomes and Cancer 3 461-467
9. Cesarman E, Chang Y, Moore PS, Said JW and Knowles DM (1995) Kaposi's sarcoma- associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332 1186-1191
10. Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN and Knowles DM (1993) CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72 3078-3090
11. Chakrabarty S, Fan D and Varani J (1990) Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. International Journal of Cancer 46 493-499
12. Chan PK, Chan FY, Leng XH, Morris SW and Liu QR (1996) Isolation and characterization of the human NPM gene. Proceedings of the American Association for Cancer Research 37 515
13. Chang JH and Olson MOJ (1990) Structure of the gene for rat nucleolar protein B23. Journal of Biological Chemistry 265 18227-18233
14. Chott A, Kaserer K, Augustin I et al. (1990) Ki-1-positive large cell lymphoma: a clinicopathologic study of 41 cases. American Journal of Surgical Pathology 14 439-448
15. DeCoteau JF, Butmarc JR, Kinney MC and Kadin ME (1996) The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87 3437-3441
16. Delabie J, Shipman R, Bruggen J et al. (1992) Expression of the novel intermediate filament- associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. Blood 80 2891-2896
17. Delsol G, Lamant L, Mariame B et al. (1997) A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 89 1483-1490
18. Derenzini M, Sirri V, Trere D and Ochs RL (1995) The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Laboratory Investigation 73 497-502
19. Dirks WG, Zaborski M, Jager K et al. (1996) The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines. Leukemia 10 142-149
20. Downing J, Ladanyi M, Raffeld M, Weiss LM and Morris SW (1995a) Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 345 918-919
21. Downing JR, Shurtleff SA, Zielenska M et al. (1995b) Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85 3416-3422
22. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B and Stein H (1992) Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68 421-427
23. Ebrahim SAD, Ladanyi M, Desai SB et al. (1990) Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes, Chromosomen and Cancer 2 27-35
24. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W and Chan WC (1995) Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 86 3517-3521
25. Filippa DA, Ladanyi M, Wollner N et al. (1996) CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 87 2905-2917
26. Frizzera G (1992) The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Seminars in Diagnostic Pathology 9 291-296
27. Fujimoto J, Shiota M, Iwahara T et al. (1996) Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proceedings of the National Academy of Sciences of the USA 93 4181-4186
28. Green I, Espiritu E, Ladanyi M et al. (1995) Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. Modern Pathology 8 39-45
29. Greer JP, Kinney MC, Collins RD et al. (1991) Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. Journal of Clinical Oncology 9 539-547
30. Gruss H-J, Boiani N, Williams DE, Armitage RJ, Smith CA and Goodwin RG (1994) Pleiotropic effects of the GD30 ligand on GD30-expressing cells and lymphoma cell lines. Blood 83 2045-2056
31. Heim S and Mitelman F (1995) Cancer Cytogenetics, 2nd ed, Wiley-Liss, New York
32. Herbst H, Tippehnann G, Anagnostoponlos I et al. (1989) Immunoglobulin and T cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leukemia Research 13 103-116
33. Herbst H, Anagnostopoulos J, Heinze B, Dürkop H, Hummel M and Stein H (1995) ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86 1694-1700
34. Iwahara T, Fujimoto J, Wen D et al. (1997) Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14 439-449
35. Jaffe ES (1995) Surgical Pathology of the Lymph Nodes and Related Organs, 2nd ed, Saunders, Philadelphia
36. Jung W, Krueger S, Renner C et al. (1994) Opposite effects of the GD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources. Molecular Immunology 31 1329-1334
37. Kadin ME (1991) Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity? Journal of Clinical Oncology 9 533-536
38. Kadin ME (1994) Ki-l/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy, journal of Clinical Oncology 12 884-887
39. Koike H, Karas RH, Baur WE, O'Donnell TF and Mendelsohn ME (1996) Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells. Journal of Vascular Surgery 23 477-482
40. Kozutsumi H, Toyoshima H, Hagiwara K, Yazaki Y and Hirai H (1994) Human Itk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo. Oncogene 9 2991-2998
41. Kuefer MU, Look AT, Tripp R, Behm FG, Pattengale PK and Morris SW (1996) Retrovirus- mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 88 450a [Abstract]
42. Ladanyi M and Cavalchire G (1996a) Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns. Diagnostic Molecular Pathology 5 154-158
43. Ladanyi M and Cavalchire G (1996b) Molecular variant of the NPM-ALK rearrangement of Ki- 1 lymphoma involving a cryptic ALK splice site. Genes, Chromosomes and Cancer 15 173-177
44. Ladanyi M, Parsa NZ, Offit K, Wachtel MS, Filippa DA and Jhanwar SC (1991) Clonal cytogenetic abnormalities in Hodgkin's disease. Genes, Chromosomes and Cancer 3 294-299
45. Ladanyi M, Cavalchire G, Morris SW, Downing J and Filippa DA (1994) Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. American journal of Pathology 145 1296-1300
46. Lamant L, Meggetto F, al Saati T et al. (1996) High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87 284-291
47. Leoncini L, Del-Vecchio MT, Kraft R et al. (1990) Hodgkin's disease and CD30-positive anaplastic large cell lymphomas: a continuous spectrum of malignant disorders: a quantitative morphometric and immunohistologic study. American Journal of Pathology 137 1047-1057
48. Liu QR and Chan PK (1991) Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein. European Journal of Biochemistry 200 715-721
49. Lau Q-R and Chan PK (1993) Characterization of seven processed pseudogenes of nucleophos- min/B23 in the human genome. DIVA and Cell Biology 12 149-156
50. Lopategui JR, Sun LH, Chan JK et al. (1995) Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. American Journal of Pathology 146 323-328
51. McWhirter JR, Calasso DL and Wang JY (1993) A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Molecular and Cellular Biology 13 7587-7595
52. Mason DY, Bastard C, Rimokh R et al. (1990) CD30 positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. British Journal of Haematology 74 161-168
53. Mathew P, Sanger W, Weisenburger DD et al. (1997) Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. Blood 98 1678-1685
54. Merz H, Houssiau FA, Orscheschek K et al. (1991) Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78 1311-1317
55. Morris SW, Kirstein MN, Valentine MB et al. (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 1281-1284
56. Morris SW, Naeve C, Mathew P et al. (1997) ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene (in press)
57. npm/alk and absence of Epstein-Barr virus. Modern Pathology 10210-215
58. O'Connor NTJ, Stein H, Gatter KG et al. (1987) Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 11 733-740
59. Offit K, Ladanyi M, Gangi MD, Ebrahim SAD, Filippa DA and Chaganti RSK (1990) Ki-1 antigen expression defines a favorable clinical subset of non-B-cell non-Hodgkin's lymphoma. Leukemia 4 625-630
60. Orscheschek K, Merz H, Hell J, Binder T, Bartels H and Feller AC (1995a) Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? Lancet 345 87-90
61. Orscheschek K, Merz H, Hell J and Feller AC (1995b) Presence of t(2;5) in Hodgkin's disease. Blood 86 4383-4384
62. Perkins PL, Ross CW and Schnitzer B (1992) CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall. Archives of Pathology and Laboratory Medicine 116 1192-1196
63. Pierotti MA, Bongarzone I, Borrello MG et al. (1995) Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas. Journal of Endocrinological Investigation 18 130-133
64. Pinto A, Gloghini A, Gattei V, Aldinucci D, Zagonel V and Carbone A (1994) Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood 83 785-792
65. Pulford K, Lamant L, Morris SW et al. (1997) Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89 1394-1404
66. Redner RL, Rush EA, Faas S, Rudert WA and Corey SJ (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87 882-886
67. Rodrigues GA and Park M (1993) Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Molecular and Cellular Biology 13 6711-6722
68. Rodrigues GA and Park M (1994) Oncogenic activation of tyrosine kinases. Current Opinion in Genetics and Development 4 15-24
69. Rosso R, Paulli M, Magrini U et al. (1990) Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen: immunohistochemical and morphological relationships to Hodgkin's disease. Virchows Archives A, Pathological Anatomy and Histopathology 416 229-235
70. Sainati L, Montaldi A, Stella M, Putti MC, Zanesco L and Basso G (1990) A novel variant translocation t(2;13)(p23;q34) in Ki-1 large cell anaplastic lymphoma. British Journal of Haematology 75 621-622
71. Santoro M, Grieco M, Melillo RM, Fusco A and Vecchio G (1995) Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. European Journal of Endocrinology 133 513-522
72. Sarris AH, Rajyalakshmi L, Valli P et al. (1996) Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 88 1771-1779
73. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T and Mori S (1994a) Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9 1567-1574
74. Shiota M, Fujimoto J, Takenaga M et al. (1994b) Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84 3648-3652
75. Shiota M, Nakamura S, Ichinohasama R et al. (1995) Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 86 1954-1960
76. Smith GA, Gruss HJ, Davis T et al. (1993) GD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 1349-1360
77. Soman NR, Correa P, Ruiz BA and Wogan GN (1991) The tpr-met oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proceedings of the National Academy of Sciences of the USA 88 4892-4896
78. Stein H and Dallenbach F (1992) Diffuse large cell lymphomas of B and T cell type, In: Knowles DM (ed). Neoplastic Hematopathology, p 675, Williams & Wilkins, Baltimore
79. Stein H, Mason DY, Gerdes J et al. (1985) The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 848-857
80. Tauchi T and Broxmeyer HE (1995) BCR/ABL signal transduction. International Journal of Hematology 61 105-112
81. ten Dijke P, Ichijo H, Franzen P et al. (1993) Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8 2879- 2887
82. Tilly H, Bastard G, Delastre T et al. (1991) Cytogenetic studies in untreated Hodgkin's disease. Blood 77 1298-1304
83. Tirelli U, Vaccher E, Zagonel V et al. (1995) CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. journal of Clinical Oncology 13 373-380
84. Tone LG, Defavery R, Scrideli CA et al. (1996) Translocation (I;5)(q32;q35) in CD30+ anaplastic large cell non-Hodgkin lymphoma of childhood. Cancer Genetics and Cytogenetics 86 83-85
85. Tong Q, Li Y, Smanik PA et al. (1995) Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene. Oncogene 10 1781-1787
86. Tsurumi H, Takahashi T, Moriwaki H and Muto Y (1992) CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease. International Journal of Hematology 56 99-102
87. Tycko B, Smith SD and Sklar J (1991) Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia. Journal of Experimental Medicine 174 867-873
88. Waggott W, Lo YMD, Bastard C et al. (1995) Detection of NPM-ALK DNA rearrangement in CD30 positive large cell lymphoma. British Journal of Haematology 89 905-907
89. Weber-Matthiesen K, Deerberg-Wittram J, Rosenwald A, Poetsch M, Grote W and Schlegel- berger B (1996) Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics. American Journal of Pathology 149 463-468
90. Weisenburger DD, Gordon BG, Vose JM et al. (1996) Occurrence of the t(2;5)(p23;q35) in non- Hodgkin's lymphoma. Blood 87 3860-3868
91. Weiss LM, Lopategui JR, Sun LH, Kamel OW, Koo CH and Glackin C (1995) Absence of the t(2;5) in Hodgkin's disease. Blood 85 2845-2847
92. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES and Raffeid M (1995) Analysis of the t(2;5)(p23;
93. Wendtner CM, Schmitt B, Gruss HJ et al. (1995) CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line. Cancer Research 55 4157-4161
94. Wood GS, Hardman DL, Boni R et al. (1996) Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodkin's disease. Blood 88 1765-1770
95. Wright DD, Sefton BM and Kamps MP (1994) Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Molecular and Cellular Biology 14 2429-2437
96. Xerri L, Carbuccia N, Parc P, Hassoun J and Birg F (1995) Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology 27 235-241
97. Xerri L, Parc P, Hassoun J and Birnbaum D (1996) Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease, journal of Pathology 178 128-132
98. Yee HT, Ponzoni M, Merson A et al. (1996) Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood 87 1081-1088
99. Yoneda N, Look AT, Kirstein MN et al. (1996) The t(3;5)(q25.1;q34) of myelodysplatic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12 265-275
100. Zuniga-Pflucker JC, Schwartz HL and Lenardo MJ (1993) Gene transcription in differentiating immature T cell receptor-neg thymocytes resembles antigen-activated mature T cells. Journal of Experimental Medicine 178 1139-1149